(Q35217857)

7 August 2017

1 reference

title

Pharmacokinetics of prostaglandins (English)

1 reference

7 August 2017

1 reference

1

Marc Bygdeman

1 reference

7 August 2017

publication date

1 October 2003

1 reference

Best Practice & Research: Clinical Obstetrics & Gynaecology

7 August 2017

published in

1 reference

7 August 2017

volume

17

1 reference

7 August 2017

issue

5

1 reference

7 August 2017

page(s)

707-716

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6934%2803%2900043-9

7 August 2017

1 reference

7 January 2021

Kinetic and metabolic studies of Prostaglandin F2-alpha administered intra-amniotically for induction of abortion

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6934%2803%2900043-9

7 January 2021

Kinetic and metabolic studies of 15-methyl-prostaglandin F2alpha administered intra-amniotically for induction of abortion

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6934%2803%2900043-9

7 January 2021

Gas chromatographic--mass spectrometric quantitation of 16, 16-dimethyl-trans-delta 2-PGE1

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6934%2803%2900043-9

7 January 2021

Absorption kinetics of misoprostol with oral or vaginal administration

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6934%2803%2900043-9

7 January 2021

Pharmacokinetics of different routes of administration of misoprostol

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6934%2803%2900043-9

7 January 2021

Comparison between oral and vaginal administration of misoprostol on uterine contractility

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6934%2803%2900043-9

7 January 2021

Vaginal misoprostol alone for medical abortion up to 9 weeks of gestation: efficacy and acceptability

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6934%2803%2900043-9

7 January 2021

Chemical instability of 15-keto-13,14-dihydro-PGE2: the reason for low assay reliability

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6934%2803%2900043-9

7 January 2021

Radioimmunologic determination of 15-keto-13,14-dihydro-PGE2: a method for its stable degradation product, 11-deoxy-15-keto-13,14-dihydro-11 beta, 16 xi-cyclo-PGE2

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6934%2803%2900043-9

7 January 2021

Development and Validation of a Radioimmunoassay for Prostaglandin E2 Metabolite Levels in Plasma*

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6934%2803%2900043-9

7 January 2021

15-Keto-13,14-dihydroprostaglandin E2- and F2 alpha-metabolite levels in blood from men and women given prostaglandin E2 orally

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6934%2803%2900043-9

7 January 2021

Radioimmunoassay of 15-keto-prostaglandin E2 in peripheral plasma after oral administration of prostaglandin E2 tablets used for induction of labour

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6934%2803%2900043-9

7 January 2021

The systemic absorption from the vagina of prostaglandin E2 administered for the induction of labour

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6934%2803%2900043-9

7 January 2021

Prostaglandin release from preparations used vaginally for the induction of labour

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6934%2803%2900043-9

7 January 2021

Transfer of prostaglandins to the fetus after prostaglandin E2 vaginal pessary administration

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6934%2803%2900043-9

7 January 2021

10.1016/S1521-6934(03)00043-9

Identifiers

DOI

1 reference

7 August 2017

1 reference